Radiopharmaceutical biotech Radionetics in fundraising mode with $54.2M so far

Ra­dio­net­ics On­col­o­gy is in the midst of a fundrais­ing dri­ve worth $68.7 mil­lion, with the Cal­i­for­nia-based com­pa­ny hav­ing raised $54.2 mil­lion so far, per an SEC fil­ing on Mon­day.

The fil­ing it­self did not dis­close who has in­vest­ed in the round so far, or what the mon­ey is ear­marked for. In Feb­ru­ary, the com­pa­ny not­ed it plans to file three INDs in 2023 and 2024. Ra­dio­net­ics did not im­me­di­ate­ly re­spond to End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.